WSB University, Poland announces a 7 days Mobility Program for PhD students in the field of Entrepreneurship.
The portfolio of activities is quite extensive:
- Active participation in a conference held abroad (including, e.g. participation in a poster session or a flash talk).
- Participation in short education forms (e.g. in courses, workshops, professional or industrial internships, study visits).
- Obtaining materials for a PhD thesis / scientific article, conformity to the field of research confirmed in the opinion of an academic supervisor.
- Participation in a summer/winter school (both as a student and a lecturer). The subject matter of the school programme must be closely related to the subject matter of the PhD thesis and/or the conducted research,
- Taking measurements with the use of unique equipment, including with the use of large research infrastructure unavailable (or not easily available) in Poland,
- Participation in trainings (including trainings related to entrepreneurship or implementation activities), carrying out archive/library queries, participation in brokerage meetings,
- Teaching,
- Participation in preparation of an international grant application,
- Other short education forms facilitating the increase in competences.
Selection criteria:
- The student age must be under 40
- The scholarship will be paid as a lump sum so there is no need to provide any bills or invoices for plane tickets, hotel, food etc. It will be paid in cash on the first day of arrival to WSB University (that means the need to pre-finance the plane ticket
Duration of mobility: 7 days
Grant:
Incoming student will receive a scholarship of approx. 460 EUR for travel expenses for a round trip and approx. 1100 EUR as subsitance allowance for food and accommodation for 7 days of stay. It will be paid in Polish currency PLN on the first day of arrival.
There is only one main condition to be met by a selected candidate: this person must be fully vaccinated (two doses) with one of the vaccines which are approved in Poland such as Pfizer, Astra Zeneca, Johnson or Moderna.
For more details please contact Prof. dr.hab. Larisa BUGAIAN ( larisa.bugaian@adm.utm.md)
